Your SlideShare is downloading. ×
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Market for Rx to OTC Switches, The
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Market for Rx to OTC Switches, The

903

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
903
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Get more info on this report!The Market for Rx to OTC SwitchesFebruary 1, 2011While many areas of the pharmaceutical industry will suffer from current economicconditions worldwide, sales of over-the-counter drugs are widely anticipated to grow asconsumers seek cheaper alternatives. Manufacturers are expected to switchprescription drugs to over-the-counter status where possible. In the early part of the lastdecade there was a decline in Rx-to-OTC switches; since 2006, however, there hasbeen a number of uses of this tactic to extend the revenue of pharmaceutical products.In Kalorama Informations Market for Rx to OTC Switches, we take a look at recentswitches, products that may switch in the future, and categories that can benefit mostfrom an OTC product.The U.S. market for Rx-to-OTC switches encompasses a wide variety of products thathave been determined safe and effective as over-the-counter products. The market isfueled by several factors including an aging population; steady to increased incidencesof conditions and diseases; new drug classes switched to OTC; product demand;economic conditions and several other factors.All product areas contribute to the growth and development of the OTC market;however, new product development and additional regulatory review and approval ofnew OTC drug classifications, specifically in areas such as gastrointestinal drugs,cholesterol-reducing drugs, and contraceptives are expected to make the most impactfor continued growth.As part of its coverage, this report includes: Current Market for Rx to OTC across major categories Past Results of OTC Switches Products Most Likely to Switch to OTC Assessment of the Economic SituationThe U.S. Market for Rx-to-OTC Switches focuses on several treatment segments inwhich Rx-to-OTC switches are available: Allergy, Cough, Cold, and Sinus Products Analgesics, NSAIDs, and Pain Treatments
  • 2. Anti-Infectives Gastrointestinal Drugs Oral Care Smoking Cessation Other Drugs, including: o Dental Rinses and Fluorides o Hair Growth Products o Rectal Ointments o Sleep Aids o Weight Management o Hormone ReplacementIn addition to the areas with switches in place, Kalorama Information has identified otherareas which may become open to Rx-to-OTC switches in the future, including:cholesterol-reducing drugs, osteoporosis treatments, overactive bladder and sexualdysfunction. The report covers OTC drugs that were once only available by prescriptiondue to either the active ingredient or dosage of the drug.Current and historical revenues for product segments include both the switched brandsand OTC drugs containing switched ingredients. Forecasted data includes currentproducts and forecasted switches which are outlined in the report.The report includes statistical information for conditions and diseases affecting the U.S.population, including detailed discussions, tables and figures. Each segment providesan overview, descriptions of products on the market, market estimates and forecasts,and competitive analysis of leading providers. In addition to above-mentionedinformation, the report includes current issues and trends affecting the industry andidentifies trends that may arise in the future.Trends covered in the report include: Healthcare Flexible Spending Accounts and OTC Medicines A Third Class of Drug Insurance Issues and Reimbursement for OTC Drugs Health Insurance Trends in the United States Impact on the Consumer Online Resources for Health Information OTC Availability Health Expenditures Pharmacists Role Impact on the Prescription Drug Manufacturer Strategies for Continued Product Growth Mergers and Acquisitions Dual Status Switching Generic Competition Direct-to-Consumer Advertising
  • 3. Patent Expiration Labeling Changes International Trends in Rx-to-OTC Switches Consumers around the World Prescription vs Over-the-Counter Industry World Health, Demographics and Life Expectancy Life Expectancy Birth RatesTable of ContentsCHAPTER ONE: EXECUTIVE SUMMARY Scope and Methodology Size and Growth of the Market Issues and Trends Affecting the Rx-to-OTC Switches Market Leading CompetitorsCHAPTER TWO: INTRODUCTION Overview of the Over-the-Counter Market Development of the Rx-to-OTC Drug Market Rx-to-OTC Industry o Economic Indicators o The FDA and Rx-to-OTC SwitchesCHAPTER THREE: ALLERGY, COUGH, COLD, AND SINUS PRODUCTS Overview o Antihistamines o Decongestants o Cough Preparations o Mast Cell Stabilizer o Ophthalmic Preparations Description of Conditions o Allergic Rhinitis o Common Cold o Sinusitis o Hives o Ocular Allergies Product Analysis o Switched Products o Antihistamines o Decongestants
  • 4. o Cough Preparations o Mast Cell Stabilizers o Ophthalmic Preparations Prescription Products with Anticipated OTC Approvals o Allegra o Xyzal o Clarinex o Astelin Nasal Spray o Flonase o Nasacort AQ o Rhinocort o Nasonex Market Analysis o Market Size and Forecast o Competitive AnalysisCHAPTER FOUR: ANALGESICS AND OTHER PAIN RELIEVERS Overview o Analgesics o Nonsteroidal Anti-inflammatory Drugs o Topical Pain Relievers and Other Similar Products Description of Conditions o Pain o Inflammation Product Analysis o Switched Ingredients  Antipruritic  Internal analgesic/antipyretic  Oral anesthetic o Prescription Products with Anticipated OTC Approvals  Nonsteroidal anti-inflammatory drugs  Voltaren (diclofenac)  Diflunisal  Etodolac  Nabumetone  Feldene (piroxicam)  Migraine treatments  Imitrex  Maxalt  Zomig  Other Migraine Treatments o Market Analysis  Market Size and Forecast  Competitive Analysis
  • 5. CHAPTER FIVE: ANTI-INFECTIVES Overview o Antibiotics o Antifungals o Antivirals o Antiparasitics Description of Conditions o Vaginal Infections o Athlete’s Foot o Jock Itch o Ringworm o Dandruff o Scabies and Pediculosis o Pinworm o Fungal Nail Infections Product Analysis o Switched Ingredients  Antifungals  Anthelmintics  Antimicrobials  Pediculicides o Prescription Products with Anticipated OTC Approvals  Antivirals  Zovirax  Valtrex  Denavir  Influenza Antivirals o Antibiotics o Antifungals Market Analysis o Market Size and Forecast o Competitive AnalysisCHAPTER SIX: GASTROINTESTINAL DRUGS Overview Description of Conditions o Nausea o Diarrhea o Constipation o Heartburn o Acid reflux Product Analysis o Switched Ingredients  Histamine H2 Inhibitors
  • 6.  Proton Pump Inhibitors  Antidiarrheals  Laxatives  Antiemetics o Prescription Products with Anticipated OTC Approvals  Proton Pump Inhibitors  Nexium  Protonix  Aciphex o Mucosal Protectants o Antiemetics o Market and Competitive Analysis  Market Size and Fore  Competitive AnalysisCHAPTER SEVEN: SMOKING CESSATION Overview Description of Conditions o Lung Cancer and Tobacco Use Product Analysis o Switched Ingredients o Prescription Products with Anticipated OTC Approvals  Nicotrol  Chantix Market Analysis o Market Size and Forecast o Competitive AnalysisCHAPTER EIGHT: OTHER DRUG CLASSIFICATIONS Overview o Contraceptives o Dental Rinses and Fluorides o Hair Growth Products o Rectal Ointments o Sleep Aids o Weight Management Description of Conditions o Pregnancy o Global Birth Rates o Abortion Rates o Contraceptive Use o Dental carries o Hereditary Hair Loss o Hemorrhoids
  • 7. o Sleeplessness o Obesity Conditions with Possible Future OTC Treatments o Acne Vulgaris o Elevated Cholesterol o Osteoporosis o Menopause and Hormone Replacement o Erectile Dysfunction o Urinary Incontinence/Overactive Bladder o Benign Prostate Hypertrophy (BPH) Product Analysis o Switched Ingredients o Contraceptives o Dental rinses and fluoride o Hair growth o Rectal ointments o Sleep aids o Weight Management o Prescription Products with Anticipated OTC Approvals o Acne Treatments o Cholesterol-reducing Drugs (antilipidemics) o Erectile Dysfunction o Hair Loss Treatment o Hormone-Replacement Therapies (HRT) o Osteoporosis Treatments o Overactive Bladder o Sleep Aids Market Analysis o Market Size and Forecast o New Product Segments; Post 2015 o Antilipidemics o Osteoporosis and Hormone Replacement o Overactive Bladder o Sexual Dysfunction o Competitive AnalysisCHAPTER NINE: TOTAL MARKET SUMMARY Overview Total market Size and Forecast Competitive Analysis Market AnalysisCHAPTER TEN: ISSUES AND TRENDS AFFECTING THE RX-TO-OTC MARKET Introduction
  • 8. Regulatory Authorities A Third Class of Drug Insurance Issues and Reimbursement for OTC Drugs o Health Insurance Trends in the United States o Healthcare Flexible Spending Accounts and OTC Medicines Impact on the Consumer o Online Resources for Health Information o OTC Availability o Health Expenditures Pharmacists Role Impact on the Prescription Drug Manufacturer Strategies for Continued Product Growth o Mergers and Acquisitions  Sanofi-Aventis and Chattem Consumer  Schering-Plough and Merck & Co.  Wyeth and Pfizer  Reckitt Benckiser and Adams Respiratory Therapeutics  Bristol-Myers Squibb and Novartis AG  Johnson & Johnson and Pfizer  Reckitt Benckiser and Boots Healthcare  Bayer and Roche o Dual Status Switching o Generic Competition o Direct-to-Consumer Advertising Patent Expiration Labeling Changes International Trends in Rx-to-OTC Switches o Consumers around the World o Prescription vs Over-the-Counter Industry o World Health, Demographics and Life Expectancy o Life Expectancy o Birth RatesCHAPTER ELEVEN: COMPANY PROFILES Introduction Bayer Healthcare Boehringer Ingelheim GlaxoSmithKline Johnson & Johnson Merck/ Schering-Plough Novartis Pfizer/Wyeth Procter & Gamble Reckitt Benckiser Sanofi-Aventis/Chattem
  • 9. Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=6065752US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004

×